Introduction
Experimental
Results
| SN | Control | Toxin | Captopril | Peganum harmala |
|---|---|---|---|---|
| Left (lesion side) | 124.6 ± 4.2†† | 49.7 ± 9.0* | 71.5 ± 2.7†† | 82.0 ± 5.3*†† |
| Right (intact side) | 130.8 ± 6.1 | 123.7 ± 10.7 | 135.3 ± 1.7 | 133.5 ± 12.0 |
Image Credit:Iran J Pharm Res
Authors
Parkinson’s disease is one of the most common neurodegenerative disorders. There are many documents about the effects of oxidative stress in Parkinson’s disease etiology. Angiotensin II activates NADPH dependent oxidases and causes superoxides formation. Peganum harmala L. extract, which has angiotensin converting enzyme (ACE) inhibitory effect, is considered to evaluate oxidative stress inhibition and Parkinson's disease improvement.
Male rats weighting 200-250 g were divided into 5 groups: Control, Neurotoxin (injection of 6-hydroxydopamine into left hemisphere substantia nigra), Peganum harmala's seeds aqueous extract (10 mg/kg) and captopril (5 mg/kg). Peganum harmala and captopril were injected intraperitonealy -144, -120, -96, -72, -48, -24, -2, 4 and 24 h relative to 6-hydroxydopamine injection time. Muscle stiffness, apomorphine induced unilateral rotation, amount of brain's protein oxidation and lipid peroxidation, ACE activity and histology of substantia nigra were assayed in all groups.
Peganum harmala improved Muscle stiffness and one-direction rotation behavior significantly. It also reduced brain's lipid and protein oxidation levels in neurotoxin-injected rats significantly. In Peganum harmala group compared to control group, brain's ACE activity was significantly inhibited. In histological study, Peganum harmala prevented degeneration of dopaminergic neurons, too.
In conclusion, aqueous extract of Peganum harmala could prevent symptoms and reduced oxidative stress markers in rats with Parkinson’s disease induced by 6-hydroxydopamine.
| SN | Control | Toxin | Captopril | Peganum harmala |
|---|---|---|---|---|
| Left (lesion side) | 124.6 ± 4.2†† | 49.7 ± 9.0* | 71.5 ± 2.7†† | 82.0 ± 5.3*†† |
| Right (intact side) | 130.8 ± 6.1 | 123.7 ± 10.7 | 135.3 ± 1.7 | 133.5 ± 12.0 |
© 2016 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fahimi S, Oryan S, Ahmadi R, Eidi A. Downregulation of Bax/Bcl-2 Expression During Apoptosis in the Hippocampus of Diabetic Male Wistar Rats: Ameliorative Effects of Peganum harmala Seed Extract. Iran J Pharm Res. 2022;21(1):e132071. doi: https://doi.org/10.5812/ijpr-132071
Jafari K, Oryan S, Ahmadi R, Eidi A. Peganum harmala Extracts as a Hypoglycemic and Hepatoprotective Agent in Diabetes-Induced Liver Damage. J Rep Pharm Sci. 2025;13(1):e147340. doi: https://doi.org/10.5812/jrps-147340
Amiri R, Fozouni L. Antibacterial Effects of Peganum harmala Seed Extracts on Drug-resistant Clinical Isolates of Acinetobacter baumannii in North of Iran. Jundishapur J Nat Pharm Prod. 2020;15(2):e92426. doi: https://doi.org/10.5812/jjnpp.92426
Erfaninejad M, Aboualigalehdari E, Fatahinia M. Effect of Peganum harmala Extract on Biofilm and Involved Gene Expression in Biofilm Production of Candida albicans. Jundishapur J Microbiol. 2023;16(2):e132692. doi: https://doi.org/10.5812/jjm-132692
Khoshzaban F, Ghaffarifar F, Jamshidi Koohsari HR. Peganum harmala Aqueous and Ethanol Extracts Effects on Lesions Caused by Leishmania major (MRHO/IR/75/ER) in BALB/c Mice. Jundishapur J Microbiol. 2014;7(7):e10992. doi: https://doi.org/10.5812/jjm.10992
Last Update: 6 days ago
Last Update: 6 days ago
Last Update: 6 days ago
Last Update: 1 hour ago
Last Update: 2 days ago
Last Update: 4 days ago